European Urology

Viewing slides 1-5 of 5

• S0302-2838(09)01165-8.title drag remove slide sort drag into slide Title The Role of BCG in the Treatment of Non Muscle Invasive Bladder Cancer
  
  Paolo Gontero [1], Andreas Bohle [2], Per-Uno Malmstrom [3], Micheal A. O'Donnell [4], Marco Oderda [1], Richard Sylvester ... The Role of BCG in the Treatment of Non Muscle Invasive Bladder Cancer Paolo Gontero [1], ... Zoom
• S0302-2838(09)01165-8.introduction drag remove slide sort drag into slide Introduction • Bacillus Calmette-Guerin (BCG) remains the most effective intravesical treatment for non-muscle-invasive bladder cancer (NMIBC)
  
  • However, the clinical development of BCG has been ... • Bacillus Calmette-Guerin (BCG) remains the most effective intravesical treatment for ... Zoom
• S0302-2838(09)01165-8.materials_and_methods drag remove slide sort drag into slide Materials and methods • A systematic literature search was performed
  
  • The Pubmed, Embase and Cochrane Central Register of Controlled Trials databases were searched for the period from 1976 to November ... • A systematic literature search was performed • The Pubmed, Embase and Cochrane ... Zoom
• S0302-2838(09)01165-8.results drag remove slide sort drag into slide Results • BCG is the most effective intravesical agent for preventing NMIBC recurrence, but its role in disease progression remains controversial
  
  • In intermediate-risk NMIBC, the superiority of ... • BCG is the most effective intravesical agent for preventing NMIBC recurrence, but its role ... Zoom
• S0302-2838(09)01165-8.conclusion drag remove slide sort drag into slide Conclusion • Although it is clear that immunocompetent host is mandatory for BCG to exert its action, factors of BCG failure remain largely unknown and unpredictable
  
  • Maintenance BCG is still the ... • Although it is clear that immunocompetent host is mandatory for BCG to exert its action, ... Zoom

Viewing slides 1-5 of 5